# 跨性别女性激素治疗与精子发生异常研究

**来源：** _BioMed Research International_
**发表日期：** 2018-04-02
**DOI:** 10.1155/2018/7919481

**作者：**
Sirachai Jindarak 1 , Kasama Nilprapha 1 , Taywin Atikankul 2 , Apichai Angspatt 1 , Pornthep Pungrasmi 1 , Seree Iamphongsai 1 , Pasu Promniyom 1 , Poonpissamai Suwajo 1 , Gennaro Selvaggi 3 , Preecha Tiewtranon 4

**单位：**

1. Division of Plastic and Reconstructive Surgery, Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
2. Division of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
3. Department of Plastic Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
4. Preecha Aesthetic Institute, Bangkok, Thailand.

**摘要：**

_客观_。测量变性女性在变性手术 (SRS) 时的精子发生异常，并分析激素治疗持续时间与不孕症严重程度之间的关联。

_设计_。回顾性研究。

_设置_。大学医院。

_患者_。2000 年 1 月至 2015 年 12 月期间接受 SRS 的 173 名跨性别_女性_。

_干预_。对所有睾丸切除术标本进行回顾性审查和分类。从医疗记录中检索激素治疗持续时间的历史。

_主要成果措施_。对睾丸切除标本进行组织学检查以评估精子发生。

_结果_. 评估了 173 个睾丸切除术标本。组织学检查显示 36.4% 的样本出现成熟停滞，26% 的精子发生不足，20.2% 的仅支持细胞综合征，11% 的精子发生正常，6.4% 的样本出现生精小管透明化。精子发生异常的严重程度与总治疗时间无关（) 或手术时的患者年龄 (）。睾丸体积和大小与精子发生异常的严重程度相关（和，右睾丸和左睾丸，分别）。

_结论_。女性化激素治疗导致睾丸生殖细胞水平降低。所有跨性别女性都应该被警告这种后果，并且在开始激素治疗之前应该提供配子保存。

![点击查看英文标题和摘要](https://scdn.x-mol.com/jcss/images/paperTranslation.png)

**英文标题和摘要：**

**Spermatogenesis Abnormalities following Hormonal Therapy in Transwomen.**

_Objective_. To measure spermatogenesis abnormalities in transwomen at the time of sex reassignment surgery (SRS) and to analyze the association between hormonal therapy duration and infertility severity.

_Design_. Retrospective study.

_Setting_. University hospital.

_Patients_. One-hundred seventy-three transwomen who underwent SRS from January 2000 to December 2015.

_Interventions_. All orchidectomy specimens were retrospectively reviewed and classified. History of hormonal therapy duration was retrieved from medical records.

_Main Outcome Measures_. Histological examinations of orchidectomy specimens were performed to assess spermatogenesis.

_Results_. One-hundred seventy-three orchidectomy specimens were evaluated. Histological examinations showed maturation arrest in 36.4%, hypospermatogenesis in 26%, Sertoli cell-only syndrome in 20.2%, normal spermatogenesis in 11%, and seminiferous tubule hyalinization in 6.4% of the specimens. Spermatogenesis abnormality severity was not associated with the total therapy duration () or patient age at the time of surgery (). Testicular volumes and sizes were associated with spermatogenesis abnormality severity ( and , right testicle and left testicle, resp.).

_Conclusion(s)_. Feminizing hormonal treatment leads to reductions in testicular germ cell levels. All transwomen should be warned about this consequence, and gamete preservation should be offered before starting hormonal treatment.
